Assessment of full-scale natural systems for the removal of PPCPs from wastewater in small communities

Water Research

Volumn 44, Issue 5, 2010, Pages 1429-1439

  Hijosa Valsero, María ^a   Matamoros, Víctor ^b   Martín Villacorta, Javier ^a   Bécares, Eloy ^a   Bayona, Josep M ^b  

^a UNIVERSITY OF LEÓN   (Spain)

^b INSTITUTE OF ENVIRONMENTAL ASSESSMENT AND WATER RESEARCH   (Spain)

Author keywords

Constructed wetland; Enantiomeric ratio; Hybrid natural systems; Ponds; PPCP

Indexed keywords

DEGRADATION; EFFICIENCY; ENANTIOMERS; HYBRID SYSTEMS; LAKES; WASTEWATER TREATMENT;

CONSTRUCTED WETLAND; ENANTIOMERIC RATIO; HORIZONTAL SUBSURFACE FLOW CONSTRUCTED WETLANDS; HYBRID NATURAL SYSTEM; NATURAL SYSTEMS; PHARMACEUTICAL AND PERSONAL CARE PRODUCTS; SMALL COMMUNITY; SURFACE FLOW CONSTRUCTED WETLANDS; URBAN WASTEWATER; WASTE WATER TREATMENT PLANTS;

WETLANDS;

DRUG; IBUPROFEN;

BIODEGRADATION; CONSTRUCTED WETLAND; DRUG; MICROBIOLOGY; POLLUTION MONITORING; SUBSURFACE FLOW; WASTE TECHNOLOGY; WASTE TREATMENT; WASTEWATER;

ARTICLE; CONSTRUCTED WETLAND; CONTROLLED STUDY; ENANTIOMER; POND; PRIORITY JOURNAL; WASTE COMPONENT REMOVAL; WASTE WATER MANAGEMENT; WASTE WATER TREATMENT PLANT;

EID: 76749170282     PISSN: 00431354     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.watres.2009.10.032     Document Type: Article

References (50)

1. Alibrandi G., Coppolino S., d'Aliberti S., Ficarra R., Micali N., and Villari A. Fast drug stability determination by LC variable parameter kinetic experiments. Journal of Pharmaceutical and Biomedical Analysis 32 (2003) 1073-1079
2. Andreozzi R., Marotta R., and Paxéus N. Pharmaceuticals in STP effuents and their solar photodegradation in aquatic environment. Chemosphere 50 (2003) 1319-1330
3. Ansola G., González J.M., Cortijo R., and de Luis E. Experimental and full-scale pilot plant constructed wetlands for municipal wastewaters treatment. Ecological Engineering 21 (2003) 43-52
4. APHA-AWWA-WPCF. Standard Methods for the Examination of Water and Wastewater. 20th ed. (2001), American Public Health Association, Washington DC, USA
5. Belmont M.A., and Metcalfe C.D. Feasibility of using ornamental plants (Zantedeschia aethiopica) in subsurface flow treatment wetlands to remove nitrogen, chemical oxygen demand and nonylphenol ethoxylate surfactants - a laboratory-scale study. Ecological Engineering 21 (2003) 233-247
6. Bendz D., Paxéus N.A., Ginn T.R., and Loge F.J. Occurrence and fate of pharmaceutically active compounds in the environment: a case study: Höje River in Sweden. Journal of Hazardous Materials 122 (2005) 195-204
7. Brain R.A., Johnson D.J., Richards S.M., Hanson M.L., Sanderson H., Lam M.W., Young C., Mabury S.A., Sibley P.K., and Solomon K.R. Microcosm evaluation of the effects of an eight pharmaceutical mixture to the aquatic macrophytes Lemna gibba and Myriophyllum sibiricum. Aquatic Toxicology 70 (2004) 23-40
8. Buser H.R., Poiger T., and Müller M.D. Occurrence and environmental behaviour of chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environmental Science and Technology 33 15 (1999) 2529-2535
9. Carballa M., Omil F., Lema J.M., Llompart M., García-Jares C., Rodríguez I., Gómez M., and Ternes T. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Research 38 12 (2004) 2918-2926
10. Carballa M., Omil F., and Lema J.M. Removal of cosmetic ingredients and pharmaceuticals in sewage primary treatment. Water Research 39 (2005) 4790-4796
11. Clara M., Strenn B., Gans O., Martínez E., Kreuzinger N., and Kroiss H. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Research 39 (2005) 4797-4807
12. Conkle J.L., White J.R., and Metcalfe C.D. Reduction of pharmaceutically active compounds by a lagoon wetland wastewater treatment system in Southeast Louisiana. Chemosphere 73 (2008) 1741-1748
13. Cottin N., and Merlin G. Removal of PAHs from laboratory columns simulating the humus upper layer of vertical flow constructed wetlands. Chemosphere 73 (2008) 711-716
14. Criado C., and Bécares E. Short Communication: Characterization of bacterial communities of a constructed wetland in cold conditions. Journal of General and Applied Microbiology 51 (2005) 197-201
15. Daughton C.G., and Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environmental Health Perspectives 107 (1999) 907-938
16. Fono L.J., and Sedlak D.L. Use of the chiral pharmaceutical propranolol to identify sewage discharges into surface waters. Environmental Science and Technology 39 23 (2005) 9244-9252
17. Gagné F., Blaise C., and André C. Occurrence of pharmaceutical products in a municipal effluent and toxicity to rainbow trout (Oncorhynchus mykiss) hepatocytes. Ecotoxicology and Environmental Safety 64 (2006) 329-336
18. García, J., Rousseau, D.P.L., Morató, J., Lesage, E., Matamoros, V., Bayona, J.M. Contaminant removal processes in subsurface-flow constructed wetlands: a review. Critical Reviews in Environmental Science and Technology, in press.
19. Huang Y., Latorre A., Barceló D., García J., Aguirre P., Mujeriego R., and Bayona J.M. Factors affecting to the linear alkylbenzene sulfonates removal in subsurface flow constructed wetlands. Environmental Science and Technology 38 (2004) 2657-2663
20. Imfeld G., Braeckevelt M., Kuschk P., and Richnow H.H. Review: monitoring and assessing processes of organic chemicals removal in constructed wetlands. Chemosphere 74 (2009) 349-362
21. Joss A., Zabczynski S., Göbel A., Hoffmann B., Löffler D., McArdell C.S., Ternes T.A., Thomsen A., and Siegrist H. Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme. Water Research 40 (2006) 1686-1696
22. Kadlec R., and Wallace S. Treatment Wetlands. second ed. (2008), CRC Press, Boca Raton, FL, USA 1016 pp.
23. Kim S.D., Cho J., Kim I.S., Vanderford B.J., and Snyder S.A. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters. Water Research 41 (2007) 1013-1021
24. Kimura K., Hara H., and Watanabe Y. Removal of pharmaceutical compounds by submerged membrane bioreactors (MBRs). Desalination 178 (2005) 135-140
25. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., and Buxton H.T. Pharmaceuticals, hormones and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environmental Science and Technology 36 6 (2002) 1202-1211
26. Lin A., and Reinhard M. Photodegradation of common environmental pharmaceuticals and estrogens in river water. Environmental Toxicology and Chemistry 24 (2005) 1303-1309
27. Lindqvist N., Tuhkanen T., and Kronberg L. Occurrence of acidic pharmaceuticals in raw and treated sewages and in receiving waters. Water Research 39 (2005) 2219-2228
28. Low D., Tan K., Anderson T., Cobb G.P., Liu J., and Jackson W.A. Treatment of RDX using down-flow constructed wetland mesocosms. Ecological Engineering 32 (2008) 72-80
29. Matamoros V., and Bayona J.M. Elimination of pharmaceuticals and personal care products in subsurface flow constructed wetlands. Environmental Science and Technology 40 (2006) 5811-5816
30. Matamoros V., García J., and Bayona J.M. Behavior of selected pharmaceuticals in subsurface flow constructed wetlands: a pilot-scale study. Environmental Science and Technology 39 (2005) 5449-5454
31. Matamoros V., Caselles-Osorio A., García J., and Bayona J.M. Behaviour of pharmaceutical products and biodegradation intermediates in horizontal subsurface flow constructed wetland. A microcosm experiment. Science of the Total Environment 394 (2008) 171-176
32. Matamoros V., García J., and Bayona J.M. Organic micropollutant removal in a full-scale surface flow constructed wetland fed with secondary effluent. Water Research 42 (2008) 653-660
33. Matamoros V., Hijosa M., and Bayona J.M. Assessment of the pharmaceutical active compounds removal in wastewater treatment systems at enantiomeric level. Ibuprofen and naproxen. Chemosphere 75 2 (2009) 200-205
34. Matamoros V., Arias C., Brix H., and Bayona J.M. Preliminary screening of small-scale domestic wastewater treatment systems for removal of pharmaceutical and personal care products. Water Research 43 (2009) 55-62
35. Matamoros V., Duhec A., Albaigés J., and Bayona J.M. Photodegradation of carbamazepine, ibuprofen, ketoprofen and 17α-ethinylestradiol in fresh and seawater. Water, Air and Soil Pollution 196 (2009) 161-168
36. Moore M.T., Rodgers Jr. J.H., Smith Jr. S., and Cooper C.M. Mitigation of metolachlor-associated agricultural runoff using constructed wetlands in Mississippi, USA. Agriculture, Ecosystems and Environment 84 (2001) 169-176
37. Park N., Vanderford B.J., Snyder S.A., Sarp S., Kim S.D., and Cho J. Effective controls of micropollutants included in wastewater effluent using constructed wetlands under anoxic condition. Ecological Engineering 35 (2009) 418-423
38. Pereira V.J., Linden K.G., and Weinberg H.S. Evaluation of UV irradiation for photolytic and oxidative degradation of pharmaceutical compounds in water. Water Research 41 (2007) 4413-4423
39. Plumlee M.H., Larabee J., and Reinhard M. Perfluorochemicals in water reuse. Chemosphere 72 (2008) 1541-1547
40. Quintana J.B., Weiss S., and Reemtsma T. Pathways and metabolites of microbial degradation of selected acidic pharmaceuticals and their occurrence in municipal wastewater treated by a membrane bioreactor. Water Research 39 (2005) 2654-2664
41. Reinoso R., and Bécares E. Environmental inactivation of Cryptosporidium parvum oocysts in waste stabilization ponds. Microbial Ecology 56 4 (2008) 585-592
42. Reinoso R., Torres L.A., and Bécares E. Efficiency of natural systems for removal of bacteria and pathogenic parasites from wastewater. Science of the Total Environment 395 (2008) 80-86
43. Richardson S.D. Water analysis: emerging contaminants and current issues. Analytical Chemistry 79 (2007) 4295-4324
44. Schulz R., Peall S.K.C., Hugo C., and Krause V. Short communication. Concentration, load and toxicity of spraydrift-borne azinphos-methyl at the inlet and outlet of a constructed wetland. Ecological Engineering 18 (2001) 239-245
45. Simonich S.L., Federle T.W., Eckhoff W.S., Rottiers A., Webb S., Sabaliunas D., and de Wolf W. Removal of fragrance materials during U.S. and European wastewater treatment. Environmental Science and Technology 36 (2002) 2839-2847
46. Stottmeister U., Wießner A., Kuschk P., Kappelmeyer U., Kästner M., Bederski O., Müller R.A., and Moormann H. Effects of plants and microorganisms in constructed wetlands for wastewater treatment. Biotechnology Advances 22 (2003) 93-117
47. Stumpf M., Ternes T.A., Wilken R.D., Vianna Rodrigues S., and Baumann W. Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil. Science of the Total Environment 225 (1999) 135-141
48. Ternes T.A., Joss A., and Siegrist H. Scrutinizing pharmaceuticals and personal care products in wastewater treatment. Environmental Science and Technology 38 (2004) 393-398
49. Ternes T.A., Bonerz M., Herrmann N., Teiser B., and Andersen H.R. Irrigation of treated wastewater in Braunschweig, Germany: an option to remove pharmaceuticals and musk fragrances. Chemosphere 66 (2007) 894-904
50. Zwiener C., and Frimmel F.H. Short-term tests with a pilot sewage plant and biofilm reactors for the biological degradation of the pharmaceutical compounds clofibric acid, ibuprofen and diclofenac. Science of the Total Environment 309 (2003) 201-211